 | • レポートコード：MRC2312MG10743 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の更年期ホルモン療法市場規模と予測を収録しています。・世界の更年期ホルモン療法市場：売上、2018年-2023年、2024年-2029年 ・世界の更年期ホルモン療法市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の更年期ホルモン療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「エストロゲン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 更年期ホルモン療法のグローバル主要企業は、Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、更年期ホルモン療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の更年期ホルモン療法市場：タイプ別、2018年-2023年、2024年-2029年 世界の更年期ホルモン療法市場：タイプ別市場シェア、2022年 ・エストロゲン、プロゲステロン 世界の更年期ホルモン療法市場：用途別、2018年-2023年、2024年-2029年 世界の更年期ホルモン療法市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の更年期ホルモン療法市場：地域・国別、2018年-2023年、2024年-2029年 世界の更年期ホルモン療法市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における更年期ホルモン療法のグローバル売上、2018年-2023年 ・主要企業における更年期ホルモン療法のグローバル売上シェア、2022年 ・主要企業における更年期ホルモン療法のグローバル販売量、2018年-2023年 ・主要企業における更年期ホルモン療法のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD ************************************************************* ・調査・分析レポートの概要 更年期ホルモン療法市場の定義 市場セグメント 世界の更年期ホルモン療法市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の更年期ホルモン療法市場規模 世界の更年期ホルモン療法市場規模：2022年 VS 2029年 世界の更年期ホルモン療法市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの更年期ホルモン療法の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の更年期ホルモン療法製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：エストロゲン、プロゲステロン 更年期ホルモン療法のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 更年期ホルモン療法の用途別グローバル売上・予測 ・地域別市場分析 地域別更年期ホルモン療法市場規模 2022年と2029年 地域別更年期ホルモン療法売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD ... |
This research report provides a comprehensive analysis of the Menopausal Hormone Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Menopausal Hormone Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Menopausal Hormone Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Menopausal Hormone Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Menopausal Hormone Therapy market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Menopausal Hormone Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Menopausal Hormone Therapy market was valued at US$ 22160 million in 2022 and is projected to reach US$ 34390 million by 2029, at a CAGR of 6.4% during the forecast period.
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:
Rising awareness of the benefits of menopausal hormone therapy: There is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social norms: Social norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
Key Features:
The research report on the Menopausal Hormone Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Menopausal Hormone Therapy market.
Market Overview: The report provides a comprehensive overview of the Menopausal Hormone Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Estrogen, Progesterone), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Menopausal Hormone Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Menopausal Hormone Therapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Menopausal Hormone Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Menopausal Hormone Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Menopausal Hormone Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Menopausal Hormone Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Menopausal Hormone Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Menopausal Hormone Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Menopausal Hormone Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Estrogen
Progesterone
Market segment by Application
Hospital
Clinic
Others
Global Menopausal Hormone Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Menopausal Hormone Therapy, market overview.
Chapter 2: Global Menopausal Hormone Therapy market size in revenue.
Chapter 3: Detailed analysis of Menopausal Hormone Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Menopausal Hormone Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Menopausal Hormone Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Menopausal Hormone Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Menopausal Hormone Therapy Overall Market Size
2.1 Global Menopausal Hormone Therapy Market Size: 2022 VS 2029
2.2 Global Menopausal Hormone Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Menopausal Hormone Therapy Players in Global Market
3.2 Top Global Menopausal Hormone Therapy Companies Ranked by Revenue
3.3 Global Menopausal Hormone Therapy Revenue by Companies
3.4 Top 3 and Top 5 Menopausal Hormone Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Menopausal Hormone Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Menopausal Hormone Therapy Players in Global Market
3.6.1 List of Global Tier 1 Menopausal Hormone Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Menopausal Hormone Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Menopausal Hormone Therapy Market Size Markets, 2022 & 2029
4.1.2 Estrogen
4.1.3 Progesterone
4.2 By Type – Global Menopausal Hormone Therapy Revenue & Forecasts
4.2.1 By Type – Global Menopausal Hormone Therapy Revenue, 2018-2023
4.2.2 By Type – Global Menopausal Hormone Therapy Revenue, 2024-2029
4.2.3 By Type – Global Menopausal Hormone Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Menopausal Hormone Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Menopausal Hormone Therapy Revenue & Forecasts
5.2.1 By Application – Global Menopausal Hormone Therapy Revenue, 2018-2023
5.2.2 By Application – Global Menopausal Hormone Therapy Revenue, 2024-2029
5.2.3 By Application – Global Menopausal Hormone Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Menopausal Hormone Therapy Market Size, 2022 & 2029
6.2 By Region – Global Menopausal Hormone Therapy Revenue & Forecasts
6.2.1 By Region – Global Menopausal Hormone Therapy Revenue, 2018-2023
6.2.2 By Region – Global Menopausal Hormone Therapy Revenue, 2024-2029
6.2.3 By Region – Global Menopausal Hormone Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Menopausal Hormone Therapy Revenue, 2018-2029
6.3.2 US Menopausal Hormone Therapy Market Size, 2018-2029
6.3.3 Canada Menopausal Hormone Therapy Market Size, 2018-2029
6.3.4 Mexico Menopausal Hormone Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Menopausal Hormone Therapy Revenue, 2018-2029
6.4.2 Germany Menopausal Hormone Therapy Market Size, 2018-2029
6.4.3 France Menopausal Hormone Therapy Market Size, 2018-2029
6.4.4 U.K. Menopausal Hormone Therapy Market Size, 2018-2029
6.4.5 Italy Menopausal Hormone Therapy Market Size, 2018-2029
6.4.6 Russia Menopausal Hormone Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Menopausal Hormone Therapy Market Size, 2018-2029
6.4.8 Benelux Menopausal Hormone Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Menopausal Hormone Therapy Revenue, 2018-2029
6.5.2 China Menopausal Hormone Therapy Market Size, 2018-2029
6.5.3 Japan Menopausal Hormone Therapy Market Size, 2018-2029
6.5.4 South Korea Menopausal Hormone Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Menopausal Hormone Therapy Market Size, 2018-2029
6.5.6 India Menopausal Hormone Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Menopausal Hormone Therapy Revenue, 2018-2029
6.6.2 Brazil Menopausal Hormone Therapy Market Size, 2018-2029
6.6.3 Argentina Menopausal Hormone Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Menopausal Hormone Therapy Revenue, 2018-2029
6.7.2 Turkey Menopausal Hormone Therapy Market Size, 2018-2029
6.7.3 Israel Menopausal Hormone Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Menopausal Hormone Therapy Market Size, 2018-2029
6.7.5 UAE Menopausal Hormone Therapy Market Size, 2018-2029
7 Menopausal Hormone Therapy Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Menopausal Hormone Therapy Major Product Offerings
7.1.4 Eli Lilly Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Menopausal Hormone Therapy Major Product Offerings
7.2.4 Pfizer Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Menopausal Hormone Therapy Major Product Offerings
7.3.4 AbbVie Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Menopausal Hormone Therapy Major Product Offerings
7.4.4 Novo Nordisk Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Menopausal Hormone Therapy Major Product Offerings
7.5.4 Merck KGaA Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Menopausal Hormone Therapy Major Product Offerings
7.6.4 Mylan Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Menopausal Hormone Therapy Major Product Offerings
7.7.4 Bayer Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Menopausal Hormone Therapy Major Product Offerings
7.8.4 Teva Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Menopausal Hormone Therapy Major Product Offerings
7.9.4 Novartis Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Menopausal Hormone Therapy Major Product Offerings
7.10.4 Abbott Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Business Overview
7.11.3 Roche Menopausal Hormone Therapy Major Product Offerings
7.11.4 Roche Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Menopausal Hormone Therapy Major Product Offerings
7.12.4 Endo International Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Ipsen
7.13.1 Ipsen Company Summary
7.13.2 Ipsen Business Overview
7.13.3 Ipsen Menopausal Hormone Therapy Major Product Offerings
7.13.4 Ipsen Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.13.5 Ipsen Key News & Latest Developments
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Company Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Major Product Offerings
7.14.4 ANI Pharmaceuticals Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.14.5 ANI Pharmaceuticals Key News & Latest Developments
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Company Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Menopausal Hormone Therapy Major Product Offerings
7.15.4 TherapeuticsMD Menopausal Hormone Therapy Revenue in Global Market (2018-2023)
7.15.5 TherapeuticsMD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer